Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured ...

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns about his personal conduct,” ...

A listeria outbreak linked to recalled pasta salads and meals has resulted in further illnesses and fatalities, US FDA warns.

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched weight-loss pill, orforglipron, and other ...

Caffeine and sugar-spiked energy drinks promise a quick pick-me-up. Yet experts say that frequently consuming these drinks ...

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...

The US Food and Drug Administration’s lead drug regulator George Tidmarsh resigned two days after being placed on administrative leave over personal conduct concerns, according to the US Department of ...

Some studies suggest that creatine supplements may reduce blood pressure, but the evidence is weak. Learn the benefits and ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

AI-driven relapse predictions could be a tool in the fight against opioid addiction. Find out how researchers used smartphone ...

UniQure , said on Monday its experimental gene therapy for Huntington's disease does not have adequate clinical data to ...